All In Biotech

Drug Trial Radar · NCT00384072

Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women

A Multicenter, Double Blind, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women

Last checked: Nov 20, 2026Latest source record: Dec 28, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

500

Planned (sponsor's estimate)

Start

May 2006

Primary completion

Not stated

Study completion Sep 2007

Sponsor

Sponsor type
Industry
First posted
Oct 4, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Prevention
Who can join
Female only, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effect of 20 mg of bazedoxifene in comparison to placebo on bone mineral density after 6 months of therapy in a population of postmenopausal Asian women.

Conditions

  • Postmenopause
  • Osteoporosis

Interventions

  • bazedoxifene BZA-20Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The percent change from baseline in lumbar spine bone mineral density (BMD) after 6 months of treatment

Locations

20 sites in 3 countries. Site status is shown where the registry gives one.

  • Site not named

    Beijing, China

  • Site not named

    Beijing, China

  • Site not named

    Nanjing, China

  • Site not named

    Shanghai, China

  • Site not named

    Shanghai, China

  • Site not named

    Shanghai, China

  • Site not named

    Tianjin, China

  • Site not named

    Tianjin, China

  • Site not named

    Tianjin, China

  • Site not named

    Seoul, South Korea

  • Site not named

    Seoul, South Korea

  • Site not named

    Seoul, South Korea

  • Site not named

    Seoul, South Korea

  • Site not named

    Seoul, South Korea

  • Site not named

    Suwon, South Korea

  • Site not named

    Kaohsuing, Taiwan

  • Site not named

    Kaoshsuing, Taiwan

  • Site not named

    Tainan, Taiwan

  • Site not named

    Taipei, Taiwan

  • Site not named

    Tapei, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.